Lv11
10 积分 2024-03-27 加入
Bioengineering and serum free expansion of blood-derived γδ T cells
5小时前
待确认
CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn
6天前
已完结
Radiotherapy as a bridging strategy for patients with relapsed or refractory large B‐cell lymphoma undergoing CAR T‐cell therapy
7个月前
已完结
Radiation Therapy as a Bridging Strategy for CAR T Cell Therapy With Axicabtagene Ciloleucel in Diffuse Large B-Cell Lymphoma
7个月前
已完结
Enhancing CAR T-cell therapy through cellular imaging and radiotherapy
7个月前
已完结
Modulation of Radiation Doses and Chimeric Antigen Receptor T Cells: A Promising New Weapon in Solid Tumors—A Narrative Review
7个月前
已完结
Ex vivo expansion of natural killer cells for clinical applications
9个月前
已完结
Phase 1 Study of SC291, a Hypoimmune, Allogeneic CD19-Directed CAR T Cell Therapy for Relapsed/Refractory B-Cell Malignancies (ARDENT) - Initial Clinical Data
11个月前
已完结
The CD47-SIRPα pathway in cancer immune evasion and potential therapeutic implications
11个月前
已完结
Phase 1 Study of SC291, a Hypoimmune, Allogeneic CD19-Directed CAR T Cell Therapy for Relapsed/Refractory B-Cell Malignancies (ARDENT) - Initial Clinical Data
11个月前
已完结
皖公网安备34019202002308
